| Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia MA Kiebish, P Tekumalla, S Ravipaty, A Dobi, S Srivastava, W Wu, S Patil, ... Scientific reports 11 (1), 15052, 2021 | 9 | 2021 |
| Hypothesis-agnostic network-based analysis of real-world data suggests ondansetron is associated with lower COVID-19 any cause mortality GM Miller, JA Ellis, R Sarangarajan, A Parikh, LO Rodrigues, C Bruce, ... Drugs-real world outcomes 9 (3), 359-375, 2022 | 2 | 2022 |
| Application of a deep learning based drug sensitivity prediction model on a novel anticancer drug NM Chand, V Vishnudas, MA Kiebish, A Thakurta, NR Narain, S Gesta, ... Cancer Research 84 (6_Supplement), 3527-3527, 2024 | | 2024 |
| Diagnostic assessment of Filamin A (FLNA) as a serum biomarker for identification of benign prostatic hyperplasia vs aggressive prostate cancer in a prospective Mexican cohort A Rodriguez, A Mendoza, M Rosenburg, JJ Castaneda, AA Melgar, ... Cancer Research 84 (6_Supplement), 3751-3751, 2024 | | 2024 |
| Filamin A Is a Prognostic Serum Biomarker for Differentiating Benign Prostatic Hyperplasia from Prostate Cancer in Caucasian and African American Men N Mahaveer Chand, PK Tekumalla, MT Rosenberg, A Dobi, A Ali, ... Cancers 16 (4), 712, 2024 | | 2024 |
| Serum Filamin A is a prognostic biomarker for screening benign prostatic hyperplasia vs prostate cancer in Caucasian and African American men NM Chand, PK Tekumalla, A Dobi, A Ali, GM Miller, JJ Aristizabal-Henao, ... Cancer Research 83 (7_Supplement), 2196-2196, 2023 | | 2023 |
| Project Survival®: Discovery of a molecular-clinical phenome biomarker panel to detect pancreatic ductal adenocarcinoma among at risk populations using high-fidelity … EM Grund, AJ Moser, CL DeCicco, NM Chand, GL Perez-Melara, ... Cancer Research 82 (12_Supplement), 5145-5145, 2022 | | 2022 |
| 1485P Identification of novel protein biomarkers for FOLFIRINOX-based chemotherapy response in advanced pancreatic adenocarcinoma using patient omics and Bayesian AI AJ Moser, M Kiebish, R Sarangarajan, NM Chand, G Miller, L Rodrigues, ... Annals of Oncology 32, S1094, 2021 | | 2021 |
| Ondansetron use is associated with lower COVID-19 mortality in a Real-World Data network-based analysis (preprint) GM Miller, AJ Ellis, R Sarangarajan, A Parikh, LO Rodrigues, C Bruce, ... | | 2021 |
| 1547P Project Survival®: High-fidelity longitudinal phenotypic and multi-omic characterization of pancreatic ductal adenocarcinoma (PDAC) for biomarker discovery AJ Moser, MA Kiebish, EM Grund, CL DeCicco, NM Chand, K Schawkat, ... Annals of Oncology 31, S947-S948, 2020 | | 2020 |
